Rajaa Nahra, MD

Amylyx Pharmaceuticals
Cambridge, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• MON-617 - Participant-Informed Design Considerations in Phase 3 LUCIDITY Trial of Avexitide for Post-Bariatric Hypoglycemia

  Monday, June 15, 2026
  9:00 AM - 2:00 PM CT